Clinical Trials on Hodgkin Lymphoma in United Kingdom
Total 5629 results
-
CelgeneActive, not recruitingLymphoma, Non-HodgkinUnited States, Italy, Austria, Canada, France, Germany, Japan, Spain, Sweden, United Kingdom
-
Acerta Pharma BVAstraZenecaCompletedDiffuse Large B Cell Lymphoma | NHL | Non-hodgkin's Lymphoma | DLBCLUnited States, United Kingdom
-
M.D. Anderson Cancer CenterRecruitingHodgkin's LymphomaUnited States
-
University of WashingtonTG Therapeutics, Inc.TerminatedHodgkin's LymphomaUnited States
-
University of FloridaCompletedEarly Markers of Radiation-Induced Cardiac Injury in Hodgkin Lymphoma Treated With Radiation TherapyHodgkin's LymphomaUnited States
-
Loyola UniversityWyeth is now a wholly owned subsidiary of PfizerTerminated
-
Gemin XCompletedHodgkin's LymphomaUnited States
-
Yogen SaunthararajahCompletedT-cell Lymphoma | Indolent B-cell Lymphoma | Aggressive B-cell Lymphoma | Non-Hodgkin's LymphomasUnited States
-
Gilead SciencesTerminated
-
University College, LondonCancer Research UK; Cancer Research UK & UCL Cancer Trials CentreCompleted
-
Montefiore Medical CenterNational Cancer Institute (NCI)Completed
-
AbbVie (prior sponsor, Abbott)CompletedFollicular Lymphoma | Non-Hodgkin's Lymphoma | Mantle Cell Lymphoma | Peripheral T-cell Lymphoma | Lymphoid Malignancies | Chronic Lymphoid LeukemiaUnited States, Canada
-
AbbVieInfinity Pharmaceuticals, Inc.WithdrawnChronic Lymphocytic Leukemia | Non-Hodgkin Lymphoma | Small Lymphocytic LymphomaUnited States
-
Reid Merryman, MDAbbVie; GenmabRecruitingFollicular Lymphoma | Low Grade Non-Hodgkin's Lymphoma, AdultUnited States
-
Tessa TherapeuticsBristol-Myers SquibbActive, not recruitingClassical Hodgkin Lymphoma | Hodgkin Disease Recurrent | Hodgkin Disease RefractoryUnited States
-
PfizerCompletedHodgkin Disease | Thrombocytopenia | Non-Hodgkin LymphomaUnited States, Russian Federation, Singapore, Australia, France, Hong Kong, Greece, Poland
-
Mirati Therapeutics Inc.TerminatedHodgkin's LymphomaUnited States, Canada
-
Greg MonohanTerminatedMultiple Myeloma | Hodgkin's Lymphoma | Non-Hodgkin's LymphomaUnited States
-
University of WashingtonMerck Sharp & Dohme LLCActive, not recruitingFollicular Lymphoma | Marginal Zone Lymphoma | Indolent B-Cell Non-Hodgkin LymphomaUnited States
-
SecuraBioCompletedIndolent Non-Hodgkin LymphomaBelgium, France, Italy, Spain, Canada, United States, Bulgaria, United Kingdom, Hungary, Georgia, Belarus, Czechia
-
Benjamin TomlinsonActive, not recruitingNon-Hodgkin LymphomaUnited States
-
Spectrum Pharmaceuticals, IncThe Leukemia and Lymphoma SocietyTerminated
-
University of Colorado, DenverChildren's Hospital ColoradoRecruitingLeukemia | Non Hodgkin LymphomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingAnn Arbor Stage III Non-Hodgkin Lymphoma | Ann Arbor Stage IV Non-Hodgkin Lymphoma | Solid NeoplasmUnited States
-
Janssen Research & Development, LLCPharmacyclics LLC.CompletedCD20-positive B-cell Non-Hodgkin LymphomaUnited States, France
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...RecruitingT-cell Acute Lymphoblastic Leukemia | T-cell Acute Lymphoblastic Lymphoma | T-non-Hodgkin LymphomaUnited States
-
Luminary TherapeuticsCase Comprehensive Cancer CenterRecruitingLymphoma, Non-Hodgkin Lymphoma, B-CellUnited States
-
Dana-Farber Cancer InstituteRecruitingLymphoproliferative Disorders | Non-Hodgkin's Lymphoma | Hodgkin's Disease | Leukemia, Lymphocytic, ChronicUnited States
-
Gilead SciencesCompletedFollicular Lymphoma | Marginal Zone Lymphoma | Small Lymphocytic Lymphoma | Indolent Non-Hodgkin's LymphomaUnited States
-
Syndax PharmaceuticalsTerminatedHodgkin's LymphomaUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruiting
-
Divaya BhutaniGenzyme, a Sanofi CompanyRecruitingIsatuximab During Stem Cell Collection and Transplant in Patients With Multiple Myeloma and LymphomaLymphoma | Multiple Myeloma | Non-Hodgkin Lymphoma | Relapsed Hodgkin's Disease, AdultUnited States
-
Indiana University School of MedicineGenzyme, a Sanofi CompanyCompletedNon Hodgkin's LymphomaUnited States
-
Astellas Pharma IncCompletedNon-Hodgkin's LymphomaUnited States, France, Spain, United Kingdom
-
CelgeneTerminatedT-cell Non-Hodgkin's LymphomaFrance, United States, Australia, Belgium
-
Innate PharmaRecruitingNon Hodgkin LymphomaUnited States, Australia
-
University of FloridaGlaxoSmithKlineTerminatedFollicular Lymphoma | Non-Hodgkin's LymphomaUnited States
-
University of NebraskaBristol-Myers SquibbRecruitingFollicular Lymphoma | Refractory Non-Hodgkin Lymphoma | High-grade B-cell Lymphoma | DLBCL - Diffuse Large B Cell Lymphoma | Relapsed Non-Hodgkin Lymphoma | Mediastinal Large B-cell Lymphoma | Indolent B-Cell Non-Hodgkin LymphomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingRecurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Recurrent Non-Hodgkin Lymphoma | Small Lymphocytic Lymphoma | Recurrent T-Cell Non-Hodgkin Lymphoma | Aggressive Non-Hodgkin... and other conditionsUnited States
-
Burzynski Research InstituteTerminatedNon Hodgkin LymphomaUnited States
-
Case Comprehensive Cancer CenterTerminatedPrimary Central Nervous System Non-Hodgkin LymphomaUnited States
-
The Christie NHS Foundation TrustUniversity of ManchesterEnrolling by invitation
-
AstraZenecaParexelActive, not recruitingRelapsed or Refractory B-cell Non-Hodgkin LymphomaUnited States, Korea, Republic of, Canada, United Kingdom, Spain, France, Denmark
-
Adam KittaiRecruitingRecurrent Transformed Non-Hodgkin Lymphoma | Recurrent Transformed B-Cell Non-Hodgkin Lymphoma | Refractory Transformed Non-Hodgkin Lymphoma | Refractory Transformed B-cell Non-Hodgkin Lymphoma | Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma | Recurrent Transformed... and other conditionsUnited States
-
BioInvent International ABRecruitingIndolent B-Cell Non-Hodgkin LymphomaSpain, United States, Brazil, Sweden, Germany, Poland
-
Mirati Therapeutics Inc.TerminatedHodgkin Lymphoma | Non-Hodgkin Lymphoma (Follicular or Large Diffuse B-cell Lymphoma or Mantle Cell Lymphoma)United States
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...RecruitingT-cell Acute Lymphoblastic Lymphoma | T-non-Hodgkin LymphomaUnited States
-
TG Therapeutics, Inc.CompletedB-cell Lymphoma | Marginal Zone Lymphoma | Primary Central Nervous System Lymphoma | Waldenstrom's Macroglobulinemia | Non-Hodgkins Lymphoma | Chronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL)United States
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...Active, not recruitingChronic Lymphocytic Leukemia | Non-Hodgkin LymphomaUnited States
-
Bristol-Myers SquibbCompletedHodgkin DiseaseCanada, United States, Belgium, Austria, Czechia, Germany, Italy, Netherlands, Spain, United Kingdom